Bausch + Lomb Pre-Tax Profit Margin 2021-2025 | BLCO
Bausch + Lomb pre-tax profit margin from 2021 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| Bausch + Lomb Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2025-03-31 | $4.83B | $-0.32B | -6.71% |
| 2024-12-31 | $4.79B | $-0.23B | -4.88% |
| 2024-09-30 | $4.68B | $-0.28B | -6.00% |
| 2024-06-30 | $4.50B | $-0.26B | -5.74% |
| 2024-03-31 | $4.31B | $-0.20B | -4.66% |
| 2023-12-31 | $4.15B | $-0.17B | -4.00% |
| 2023-09-30 | $3.97B | $-0.11B | -2.80% |
| 2023-06-30 | $3.90B | $-0.06B | -1.46% |
| 2023-03-31 | $3.81B | $-0.01B | -0.29% |
| 2022-12-31 | $3.77B | $0.07B | 1.94% |
| 2022-09-30 | $3.77B | $0.16B | 4.27% |
| 2022-06-30 | $3.78B | $0.23B | 6.08% |
| 2022-03-31 | $3.77B | $0.27B | 7.16% |
| 2021-12-31 | $3.77B | $0.32B | 8.45% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $4.050B | $4.791B |
| Bausch Lomb Corporation is an eye health company. Its product portfolio includes Biotrue(R) and renu(R) multi-purpose solutions, Biotrue(R) ONEday daily disposable contact lenses, LUMIFY(R) redness reliever eye drops, PreserVision(R) AREDS 2 formula eye vitamin and mineral supplements and VYZULTA(R). Bausch Lomb Corporation is based in VAUGHAN, ON. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $135.269B | 25.37 |
| Elevance Health (ELV) | United States | $85.392B | 11.02 |
| CVS Health (CVS) | United States | $79.000B | 9.82 |
| Cencora (COR) | United States | $56.052B | 19.50 |
| DiDi Global (DIDIY) | China | $22.921B | 34.79 |
| Natera (NTRA) | United States | $22.013B | 0.00 |
| BioMerieux (BMXMF) | France | $15.348B | 0.00 |
| Solventum (SOLV) | United States | $12.566B | 13.30 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.094B | 0.00 |
| CochLear (CHEOY) | Australia | $11.426B | 0.00 |
| Revvity (RVTY) | United States | $10.766B | 18.53 |
| ICON (ICLR) | Ireland | $10.566B | 9.82 |
| Viatris (VTRS) | United States | $10.082B | 3.46 |
| Doximity (DOCS) | United States | $9.641B | 44.90 |
| Avantor (AVTR) | United States | $8.879B | 12.90 |
| HealthEquity (HQY) | United States | $8.778B | 43.18 |
| Medpace Holdings (MEDP) | United States | $8.445B | 22.43 |
| Sonic Healthcare (SKHHY) | Australia | $8.256B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.692B | 13.11 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 27.18 |
| BrightSpring Health Services (BTSG) | United States | $4.042B | 37.42 |
| Sotera Health (SHC) | United States | $3.463B | 19.68 |
| Alignment Healthcare (ALHC) | United States | $2.978B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.933B | 38.14 |
| Concentras Parent (CON) | United States | $2.751B | 15.90 |
| Organon (OGN) | United States | $2.379B | 2.53 |
| Ardent Health Partners (ARDT) | United States | $2.120B | 9.04 |
| GeneDx Holdings (WGS) | United States | $1.998B | 76.94 |
| Premier (PINC) | United States | $1.885B | 14.31 |
| Progyny (PGNY) | United States | $1.822B | 40.09 |
| PACS (PACS) | United States | $1.494B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.354B | 27.07 |
| Teladoc Health (TDOC) | United States | $1.223B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.179B | 8.97 |
| Establishment Labs Holdings (ESTA) | $1.038B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| CareDx (CDNA) | United States | $0.978B | 15.27 |
| Agilon Health (AGL) | United States | $0.973B | 0.00 |
| Nutex Health (NUTX) | United States | $0.921B | 13.92 |
| AMN Healthcare Services Inc (AMN) | United States | $0.810B | 7.58 |
| QDM (QDMI) | Hong Kong, SAR China | $0.743B | 0.00 |
| Embecta (EMBC) | United States | $0.617B | 4.15 |
| InnovAge Holding (INNV) | United States | $0.547B | 0.00 |
| Enhabit (EHAB) | United States | $0.525B | 43.17 |
| LifeMD (LFMD) | United States | $0.521B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.479B | 10.78 |
| SBC Medicals (SBC) | United States | $0.466B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.465B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.395B | 0.00 |
| Oncology Institute (TOI) | United States | $0.278B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.220B | 0.00 |
| Beauty Health (SKIN) | United States | $0.208B | 0.00 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| KindlyMD (NAKA) | United States | $0.146B | 0.00 |
| DocGo (DCGO) | United States | $0.139B | 22.67 |
| OncoCyte (OCX) | United States | $0.095B | 0.00 |
| So-Young (SY) | China | $0.090B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.065B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.062B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Biodesix (BDSX) | United States | $0.050B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.039B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.032B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.019B | 0.00 |
| ModivCare (MODV) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |